Apex Healthcare Bhd (7090) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.038x

Based on the latest financial reports, Apex Healthcare Bhd (7090) has a cash flow conversion efficiency ratio of 0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM29.41 Million ≈ $7.38 Million USD) by net assets (RM779.26 Million ≈ $195.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View current stock price of Apex Healthcare Bhd for real-time trading data and today's change.

Apex Healthcare Bhd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Apex Healthcare Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see market value of Apex Healthcare Bhd for the company's overall valuation and market capitalisation.

Apex Healthcare Bhd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Apex Healthcare Bhd ranked by their cash flow conversion efficiency. Also see 7090 current and non-current assets for a full breakdown of the balance sheet.

Company Cash Flow Conversion Efficiency
Hind Rectifiers Limited
NSE:HIRECT
0.333x
VIP Industries Limited
NSE:VIPIND
0.136x
Ari Real Estate Arena Investment Ltd
TA:ARIN
0.014x
Lifestyle Communities Ltd
AU:LIC
0.028x
HelloFresh SE
XETRA:HFG
0.201x
Wajax Corporation
TO:WJX
0.026x
Jing Jin Electric Technologies Co Ltd
SHG:688280
0.340x
Diamond Hill Investment Group Inc
NASDAQ:DHIL
0.095x

Annual Cash Flow Conversion Efficiency for Apex Healthcare Bhd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Apex Healthcare Bhd from 2012 to 2024. Review how financially flexible is Apex Healthcare Bhd to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 RM789.62 Million
≈ $198.25 Million
RM69.00 Million
≈ $17.32 Million
0.087x +23.08%
2023-12-31 RM918.27 Million
≈ $230.55 Million
RM65.19 Million
≈ $16.37 Million
0.071x -44.99%
2022-12-31 RM558.43 Million
≈ $140.20 Million
RM72.07 Million
≈ $18.09 Million
0.129x +5.82%
2021-12-31 RM506.86 Million
≈ $127.26 Million
RM61.82 Million
≈ $15.52 Million
0.122x -33.24%
2020-12-31 RM467.97 Million
≈ $117.49 Million
RM85.49 Million
≈ $21.46 Million
0.183x +13.81%
2019-12-31 RM425.53 Million
≈ $106.84 Million
RM68.30 Million
≈ $17.15 Million
0.161x +53.12%
2018-12-31 RM385.99 Million
≈ $96.91 Million
RM40.46 Million
≈ $10.16 Million
0.105x -22.33%
2017-12-31 RM343.23 Million
≈ $86.17 Million
RM46.32 Million
≈ $11.63 Million
0.135x +24.58%
2016-12-31 RM311.97 Million
≈ $78.33 Million
RM33.80 Million
≈ $8.49 Million
0.108x +35.65%
2015-12-31 RM288.00 Million
≈ $72.31 Million
RM23.00 Million
≈ $5.77 Million
0.080x -40.67%
2014-12-31 RM260.00 Million
≈ $65.28 Million
RM35.00 Million
≈ $8.79 Million
0.135x +17.17%
2013-12-31 RM235.00 Million
≈ $59.00 Million
RM27.00 Million
≈ $6.78 Million
0.115x -19.95%
2012-12-31 RM216.00 Million
≈ $54.23 Million
RM31.00 Million
≈ $7.78 Million
0.144x --

About Apex Healthcare Bhd

KLSE:7090 Malaysia Medical Distribution
Market Cap
$473.43 Million
RM1.89 Billion MYR
Market Cap Rank
#12615 Global
#135 in Malaysia
Share Price
RM2.61
Change (1 day)
+0.00%
52-Week Range
RM2.35 - RM2.64
All Time High
RM3.34
About

Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, ant… Read more